Latest Options News

Sunrise Energy Metals has successfully completed a scaled-back Share Purchase Plan, raising $1.5 million and bringing total capital raised to $7.5 million to advance its flagship Syerston Scandium Project.

Sarama Resources has raised A$2.7 million through a well-supported equity placement to fund a maiden drilling campaign in Western Australia's Laverton Gold District and advance its arbitration claim against Burkina Faso.

Copper Search Limited has successfully raised approximately $275,175 through a non-renounceable entitlement offer, issuing over 16 million new shares and accompanying options. Additional placements and broker options are pending shareholder approval, setting the stage for potential capital expansion.

Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.

Torque Metals is initiating a targeted 6,500-metre drilling program at its Paris Gold Project, leveraging advanced electromagnetic surveying to unlock new high-grade gold zones and potentially grow its resource base.

Theta Gold Mines has approved the Decision to Mine for its TGME Gold Project in South Africa and raised US$4 million through a private placement, advancing its path toward production amid rising gold prices.

ECS Botanics has launched the globally acclaimed Terphogz™ cannabis strains, including The Original Z™, into the Australian medicinal market, marking a strategic expansion of its premium product portfolio.

Estrella Resources has confirmed a $5 million capital injection from a strategic investor exercising a tranche subscription option, underpinning its ambitious manganese and limestone projects in Timor-Leste.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

Lodestar Minerals announces a $2.2 million two-tranche capital raising to advance its Chile exploration projects and evaluate new opportunities, signaling renewed investor confidence.

New World Resources and Central Asia Metals have agreed to increase their takeover offer to 6.2 cents per share, surpassing a competing bid and reshaping the acquisition landscape.

Dimerix Limited has received a significant milestone payment from its Japanese partner FUSO Pharmaceutical, marking progress in the Phase 3 clinical trial of DMX-200 for kidney disease. This payment underscores the growing momentum behind Dimerix’s global licensing strategy.